PCOS and Brain Health
Official title: Functional and Structural Impacts of Polycystic Ovary Syndrome (PCOS) on Brain Health
Run by University of Wisconsin, Madison · NCT07727512 · Data updated 2026-11-12
This study tests how PCOS may affect brain blood flow, brain structure, and thinking skills in reproductive-age people with and without PCOS.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years to 45 Years |
| Sex | Women only |
| Enrollment | 45 (estimated) |
| Sponsor | University of Wisconsin, Madison Academic / other |
| Locations | 1 site (Madison, Wisconsin) |
| Status | Recruiting |
| Started | August 7, 2026 |
| Main results expected | August 2028 |
| Study ends | August 2028 |
| Registry record updated | August 21, 2026 |
| Trial ID | NCT07727512 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Reproductive-age adults (18-45) with ovaries, diagnosed with PCOS by Rotterdam criteria, and healthy controls without PCOS.
✕Probably not a fit
Some participants may not experience any direct personal benefit from participation.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study uses MRI and cognitive testing to compare brain blood flow, structure, and connectivity between individuals with PCOS and healthy controls. Participants will undergo two testing visits over 1 to 3 months, including MRI scans and lab work, totaling about 5 hours. The study also looks at immune and metabolic profiles to see how they relate to brain measures and cognition. Findings may reveal brain and systemic differences associated with PCOS and guide future research on brain health in this population.
Why it matters
Potential benefit: If successful, the study could improve understanding of brain health in PCOS and inform future interventions to protect or optimize cognitive and brain function.
How similar studies have gone: Previous research in PCOS has explored metabolic and hormonal aspects; brain-focused investigations are emerging but not yet widespread.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria (Participants with PCOS): * Rotterdam criteria demonstrating two out of the three criteria. These are: 1. Presence of clinical hyperandrogenism or biochemical hyperandrogenism 2. A history of irregular menstrual cycles 3. Presence of polycystic ovarian morphology on ultrasound Inclusion Criteria (Healthy Controls): * Regular menstrual cycles (not meeting criteria for irregular cycles above) * No diagnosis of PCOS * Controls may have isolated hirsutism or polycystic ovaries on ultrasound as long as they do not meet Rotterdam criteria for PCOS Exclusion Criteria: * Current pregnancy * Preexisting diagnosis of type 1 diabetes * Severe obesity (body mass index (BMI) greater than 45kg/m2) * Preexisting diagnosis of hypertension requiring antihypertensive medication or blood pressure of greater than 160/100 on two separate occasions during clinical care * History of neurologic disease or stroke * History of myocardial infarction or deep venous thrombosis * Endometriosis confirmed by prior laparoscopy * Autoimmune conditions including lupus, multiple sclerosis, and active malignancy * Immuno-modulating medications * Conditions incompatible with MRI scanning, including but not limited to * Certain implanted metal devices or foreign bodies * Severe claustrophobia * Post-menopausal * Participants will be excluded if they have taken hormonal contraception or fertility medication in the last month
Where it's running
-
University of Wisconsin
Madison, Wisconsin, United States Recruiting
Study contacts
- Principal investigator: Laura Cooney, MD — University of Wisconsin, Madison
- Study coordinator: Sharon Blohowiak
- Email: sblohowiak@wisc.edu
- Phone: (608) 262-5977
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
PMOS and Sleep Apnea: A Pilot Look at Mitochondrial Function
In women with PMOS, this pilot study tests whether sleep apnea treatment with CPAP improves mitochondrial function in leg muscle tissue.
-
Adding cabergoline to letrozole for ovulation in PCOS
This study will see if adding cabergoline to letrozole helps women with PCOS ovulate more often.
-
Investigating cardiovascular markers in women with PCOS during glucose testing
This study is testing how glucose testing affects heart health markers in women with PCOS and whether different treatments can improve those markers over six months.
-
PIMS versus PGT-A for embryo selection in women with PCOS
This test will see if selecting embryos with Pre-implantation Methylation Screening (PIMS) instead of PGT-A plus standard morphology leads to higher cumulative live birth rates and lower early pregnancy loss for women with PCOS undergoing IVF/ICSI.
-
Comparing adipokine levels in women with and without PCOS
This study is trying to see how levels of certain fat-related proteins differ in women with polycystic ovary syndrome (PCOS), both with and without insulin resistance, compared to women without PCOS.
-
Using liraglutide to improve fertility in obese women with PCOS
This study is testing if giving liraglutide, along with metformin, can help obese women with PCOS improve their chances of having a baby through IVF by losing weight and getting healthier.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.